Energesis Pharmaceuticals Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $100K

  • Investors
  • 5

Energesis Pharmaceuticals General Information

Description

Developer of therapeutic drugs designed for the treatment of diabetes, obesity, and lipid disorders. The company's approach is a novel strategy leveraging recent scientific insights in brown adipose tissue biology to increase the body's ability to burn stored fat and lower insulin resistance, enabling patients with drugs that increase energy expenditure, a strategy for addressing both obesity and diabetes.

Contact Information

Website
www.energesispharma.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • One Kendall Square Building 200
  • Suite 2203
  • Cambridge, MA 02139
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Vertical(s)
Life Sciences
Corporate Office
  • One Kendall Square Building 200
  • Suite 2203
  • Cambridge, MA 02139
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Energesis Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 30-Jun-2021 $100K Completed Generating Revenue
3. Grant 01-Jul-2020 Completed Generating Revenue
2. Grant 26-May-2015 $1.49M $50K Completed Generating Revenue
1. Accelerator/Incubator 21-Oct-2010 $50K $50K Completed Startup
To view Energesis Pharmaceuticals’s complete valuation and funding history, request access »

Energesis Pharmaceuticals Patents

  • 46

    Total Documents Applications and Grants

  • Total Patents Families

  • 23

    Granted

  • 17

    Pending

  • Expiring in next 12 mo

Energesis Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022276512-A1 Methods and compositions for inducing brown adipogenesis Pending 20-May-2021
CA-3218880-A1 Methods and compositions for inducing brown adipogenesis Pending 20-May-2021
US-20240238374-A1 Methods and compositions for inducing brown adipogenesis Pending 20-May-2021
EP-4340824-A1 Methods and compositions for inducing brown adipogenesis Pending 20-May-2021
EP-4208188-A1 Analogs of human fibroblast growth factors Pending 19-Aug-2020 C07K14/50
To view Energesis Pharmaceuticals’s complete patent history, request access »

Energesis Pharmaceuticals Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
MassVentures Venture Capital Minority
Massachusetts Life Sciences Center Government
United States Department of Defense Government
U.S. Department of Health and Human Services Government
MassChallenge Accelerator/Incubator
To view Energesis Pharmaceuticals’s complete investors history, request access »

Ready to get started?

Request a free trial

Energesis Pharmaceuticals FAQs

  • When was Energesis Pharmaceuticals founded?

    Energesis Pharmaceuticals was founded in 2009.

  • Where is Energesis Pharmaceuticals headquartered?

    Energesis Pharmaceuticals is headquartered in Cambridge, MA.

  • What industry is Energesis Pharmaceuticals in?

    Energesis Pharmaceuticals’s primary industry is Biotechnology.

  • Is Energesis Pharmaceuticals a private or public company?

    Energesis Pharmaceuticals is a Private company.

  • What is Energesis Pharmaceuticals’s current revenue?

    The current revenue for Energesis Pharmaceuticals is .

  • How much funding has Energesis Pharmaceuticals raised over time?

    Energesis Pharmaceuticals has raised $50K.

  • Who are Energesis Pharmaceuticals’s investors?

    MassVentures, Massachusetts Life Sciences Center, United States Department of Defense, U.S. Department of Health and Human Services, and MassChallenge have invested in Energesis Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »